Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation

Completed · Phase 2

Conditions studied: Oral Complications, Unspecified Childhood Solid Tumor, Protocol Specific

In brief

RATIONALE: Glutamine may be able to decrease inflammation of the mouth and digestive system in children who are undergoing stem cell transplantation. PURPOSE: Randomized double-blinded phase II trial to study the effectiveness of glutamine in reducing inflammation of the mouth and digestive system in children who are undergoing peripheral stem cell transplantation.

Key facts

Study ID

NCT00003898

Run by

Roswell Park Cancer Institute

People needed

120

Starts

1999-01-01

Expected to finish

2004-01-01

Last updated by the study team

2011-03-01

Who can join

Age: 1 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Roswell Park Cancer Institute — Buffalo, New York, United States
• Simmons Cancer Center - Dallas — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.